ATE244697T1 - Phenylester-derivate von alpha-aminosäuren - Google Patents

Phenylester-derivate von alpha-aminosäuren

Info

Publication number
ATE244697T1
ATE244697T1 AT99936544T AT99936544T ATE244697T1 AT E244697 T1 ATE244697 T1 AT E244697T1 AT 99936544 T AT99936544 T AT 99936544T AT 99936544 T AT99936544 T AT 99936544T AT E244697 T1 ATE244697 T1 AT E244697T1
Authority
AT
Austria
Prior art keywords
phenylester
alpha
derivatives
amino acids
acids
Prior art date
Application number
AT99936544T
Other languages
English (en)
Inventor
Niall Morton Hamilton
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE244697T1 publication Critical patent/ATE244697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99936544T 1998-07-22 1999-07-16 Phenylester-derivate von alpha-aminosäuren ATE244697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98305837 1998-07-22
PCT/EP1999/005051 WO2000005196A1 (en) 1998-07-22 1999-07-16 α-AMINO ACID PHENYL ESTER DERIVATIVES

Publications (1)

Publication Number Publication Date
ATE244697T1 true ATE244697T1 (de) 2003-07-15

Family

ID=8234960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936544T ATE244697T1 (de) 1998-07-22 1999-07-16 Phenylester-derivate von alpha-aminosäuren

Country Status (27)

Country Link
US (1) US6451854B1 (de)
EP (1) EP1098871B1 (de)
JP (1) JP2002521358A (de)
KR (1) KR100599142B1 (de)
CN (1) CN1183101C (de)
AR (1) AR021165A1 (de)
AT (1) ATE244697T1 (de)
AU (1) AU758808B2 (de)
BR (1) BR9912291A (de)
CA (1) CA2337945A1 (de)
CO (1) CO5080742A1 (de)
DE (1) DE69909486T2 (de)
DK (1) DK1098871T3 (de)
ES (1) ES2203163T3 (de)
HU (1) HUP0102705A3 (de)
ID (1) ID27261A (de)
IL (1) IL140586A (de)
NO (1) NO20010280L (de)
NZ (1) NZ509327A (de)
PE (1) PE20000880A1 (de)
PL (1) PL345621A1 (de)
PT (1) PT1098871E (de)
RU (1) RU2223947C2 (de)
SK (1) SK1032001A3 (de)
TR (1) TR200100166T2 (de)
TW (1) TW565546B (de)
WO (1) WO2000005196A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031473A1 (es) * 2000-11-20 2003-09-24 Lundbeck & Co As H Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
ATE328864T1 (de) 2001-01-19 2006-06-15 Akzo Nobel Nv Alanin-2,6-dialkoxyphenylesterderivate als hypnotika
CN120965524B (zh) * 2025-10-21 2026-01-09 四川大学 一种(n,n-二甲基氨基)甲酸-4,5-二甲氧基-2-[(1e)-3-甲氧基-丙烯基]苯基酯化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1102011A (en) * 1964-05-21 1968-02-07 Richardson Merrell Spa Phenol esters of amino acids
GB1160468A (en) 1967-05-08 1969-08-06 May & Baker Ltd Morpholine Derivative
SU495828A3 (ru) * 1972-10-12 1975-12-15 Ф.Гоффманн-Ля Рош И Ко Аг. (Фирма) Способ получени мета-производных бензойной кислоты

Also Published As

Publication number Publication date
PL345621A1 (en) 2002-01-02
KR100599142B1 (ko) 2006-07-12
IL140586A (en) 2004-06-01
NZ509327A (en) 2003-04-29
TR200100166T2 (tr) 2001-05-21
RU2223947C2 (ru) 2004-02-20
HUP0102705A3 (en) 2002-11-28
HUP0102705A2 (hu) 2001-12-28
IL140586A0 (en) 2002-02-10
CN1311770A (zh) 2001-09-05
AU5160299A (en) 2000-02-14
NO20010280L (no) 2001-03-08
WO2000005196A1 (en) 2000-02-03
TW565546B (en) 2003-12-11
KR20010071905A (ko) 2001-07-31
CA2337945A1 (en) 2000-02-03
NO20010280D0 (no) 2001-01-17
ID27261A (id) 2001-03-22
DE69909486D1 (de) 2003-08-14
JP2002521358A (ja) 2002-07-16
DE69909486T2 (de) 2004-05-27
CO5080742A1 (es) 2001-09-25
EP1098871B1 (de) 2003-07-09
DK1098871T3 (da) 2003-10-27
CN1183101C (zh) 2005-01-05
PT1098871E (pt) 2003-11-28
AR021165A1 (es) 2002-07-03
AU758808B2 (en) 2003-03-27
ES2203163T3 (es) 2004-04-01
US6451854B1 (en) 2002-09-17
EP1098871A1 (de) 2001-05-16
SK1032001A3 (en) 2001-08-06
PE20000880A1 (es) 2000-09-12
BR9912291A (pt) 2001-04-17

Similar Documents

Publication Publication Date Title
ATE263147T1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE59709450D1 (de) Aluminiumsalze von Phosphinsäuren
FI942423A7 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
DE69832490D1 (de) Vervielfältigung von nukleinsäuren
DE69941116D1 (de) G von gdf-8
EE200000573A (et) Asendatud indoolalkaanhapped
DE60033896D1 (de) Unterscheidung von Modulationsarten
DE69823016D1 (de) Wässrige lösungen von salicylsaure derivaten
DE69623360D1 (de) Schätzung von Anregungsparametern
DE69814069D1 (de) Neuartige form von s-omeprazol
EP1294513A4 (de) Lokalisationsspezifische kovalente biokonjugation von proteinen
ATE257836T1 (de) Salz von naphthyridincarbonsäure-derivaten
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
ATE238984T1 (de) Sulfonylaminocarbonsäuren
DE69727986D1 (de) Erkennung von extravasation
DE69702805D1 (de) Vielseitige Massstabsveränderung von Zeichnungen
DE69518454D1 (de) Abschätzung von Anregungsparametern
FI962932L (fi) Ankkuriproteiinifunktion modulaattoreita
DE69905054D1 (de) KRISTALLINE FORMEN VON EtO2C-CH2-(R)Cgl-Aze-Pab-OH
ATE264069T1 (de) Verstärkung von nahrungsmitteln
DE69907146D1 (de) Direkte oxidation von cycloalkanen
DE69801676D1 (de) Wässrige emulsionen von fischer-tropschparaffinen
DE69921311D1 (de) Vervielfältigung von nukleinsäuren
ATE207065T1 (de) Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1098871

Country of ref document: EP

REN Ceased due to non-payment of the annual fee